Seres Therapeutics, Inc.

MA · United States · Reporting entity ID 100001351933

Total reported 2019–2025

$2.03M

#1,030 of 2,960 reporting companies — 0% of all reported industry payments

$150K in general payments across 58 records, plus $1.88M in research funding across 255 records.

How it breaks down

General payments $150,496

Research funding $1,883,694

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.